US Patent Issued to HUA Medicine (Shanghai) on June 3 for "Pharmaceutical combination and composition, and combination preparation containing glucokinase activator and biguanide hypoglycemic drug as well as preparation method and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., June 4 -- United States Patent no. 12,318,366, issued on June 3, was assigned to HUA Medicine (Shanghai) Ltd. (Shanghai).

"Pharmaceutical combination and composition, and combination preparation containing glucokinase activator and biguanide hypoglycemic drug as well as preparation method and use thereof" was invented by Li Chen (Shanghai), Yongguo Li (Shanghai) and Gaosen Wang (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "A pharmaceutical combination. The pharmaceutical combination contains a glucokinase activator or a pharmaceutically acceptable salt thereof, an isotopic marker thereof, a crystalline form thereof, a hydrate, a solvate, a diastereoisomer or an enantiomer form, an...